evolcSign inStart free
Menu

Pentabind

AI-designed aptamers and molecular discovery services for biotech, diagnostics and therapeutics partners

London, United KingdomFounded 2021pentabind.co.ukWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2021
  • Hiring1 open role
  • New on EvolcAdded 2026-11-07

About Pentabind

PentaBind develops AI-designed aptamers using computational models, molecular modelling and an integrated wet laboratory. Its platform supports aptamer discovery and development for sensing, diagnostics and therapeutic applications, including oncology.

The company works with commercial and research partners through partnerships and services, which generate revenue and data for its pipeline. It is VC-backed and described as a pre-seed startup, with a laboratory in White City and a Scientist I role listed in London.

PentaBind Ltd was founded in 2021 and is headquartered in London, United Kingdom.

Product: An AI and wet-lab platform for designing and validating aptamers, plus discovery and development services for sensing and therapeutic applications.

Jobs at Pentabind (1)

Pentabind is hiring for one role in data & AI, based in London.

  • Scientist I

    London, United KingdomOn-siteJuniortoday
    Young companyNew on Evolc

Companies hiring like Pentabind

More biotech & pharma companies

  • Peptone

    Drug discovery platform designing small-molecule candidates for hard-to-treat cancers and neurodegenerative disease targets
    Mansfield, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

  • Petagene

    Genomic data compression, cloud access and encryption software for genomics researchers and bioinformatics teams
    Cambridge, United KingdomBiotech & pharmaFounded 20161 open job
    New on Evolc

  • Pheno Therapeutics

    Develops GPR17-targeting neuroprotective therapeutics for patients with multiple sclerosis and other neurological disorders
    Edinburgh, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

  • Phoremost

    Biotech developing oral small-molecule cancer drugs, lead programme PMC-001 for primary and metastatic brain cancers
    Cambridge, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Phynova Group

    Develops plant-derived health ingredients, including Reducose for blood glucose, for supplement, food and beverage makers
    Banbury, United KingdomBiotech & pharmaFounded 2004
    New on Evolc

  • Plaquetec

    Coronary artery disease endotyping and biomarker discovery for drug developers, using in-vivo plaque sampling
    Cambridge, United KingdomBiotech & pharmaFounded 2007
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • PlausibleHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • WixHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • ReactMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Marketing & advertising

  • ApolloMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Monitoring

  • SentryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.